Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Classificação em ações #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Preço da ação
$1.51
Última sincronização: 2024-08-26
Valor de mercado
$1.12M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Agile Therapeutics, Inc. (AGRX)

Categoria

Lucros da Agile Therapeutics, Inc. (AGRX)
Lucros em Jun 2024 TTM: $-15.86M
De acordo com os últimos relatórios financeiros da Agile Therapeutics, Inc., os ganhos atuais da empresa são de $-15.86M. Em 2022, a empresa teve ganhos de $-30.09M, um aumento em relação a aos ganhos de 2021, que foram de $-74.89M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Agile Therapeutics, Inc. de 2012 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-15.86M 9.62%
2023 $-14.47M -51.92%
2022 $-30.09M -59.83%
2021 $-74.89M 44.44%
2020 $-51.85M 178.69%
2019 $-18.61M -8.15%
2018 $-20.26M -28.43%
2017 $-28.30M -11.04%
2016 $-31.82M -12.37%
2015 $-36.31M 84.02%
2014 $-19.73M 37.77%
2013 $-14.32M -38.43%
2012 $-23.26M 0.00%
Lucros de empresas semelhantes ou concorrentes